Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Patients should stay informed about current FDA guidance and confirm that their telehealth platform and pharmacy are operating in compliance with current federal and state compounding regulations
Retatrutide works like other weight loss and type 2 diabetes medications, but what makes it different is that it can target three receptors (triple agonist) at once: Gastric inhibitory polypeptide receptor (GIP) Glucagon-like peptide-1 receptor (GLP-1) Glucagon receptors (GCG) This unique triple-action may make it more effective than GLP-1 and GLP-1/GIP medications
Many clients find it convenient to take their injection in the evening, as it allows them to relax and not have to worry about it during their busy daytime hours
The peptide consistently demonstrates protective effects against various forms of organ damage in animal models
A 2024 KFF study found Medicaid coverage could benefit 40% of adults and 26% of children with obesity, forcing policymakers to weigh cost, equity and long-term health outcomes as demand grows and new uses emerge
